Stoke Therapeutics (0GT) Financial Statements
Stoke Therapeutics Financial Overview
Stoke Therapeutics's market cap is currently $1.52B. The company's EPS TTM is $-3.36; its P/E ratio is -6.94; Stoke Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 184.42M | $ 36.55M | $ 8.78M | $ 12.40M | $ 0.00 |
| Gross Profit | $ 184.42M | $ 36.55M | $ 8.78M | $ 12.40M | $ 0.00 |
| Operating Income | $ -20.59M | $ -101.37M | $ -114.77M | $ -104.36M | $ -86.06M |
| EBITDA | $ -5.12M | $ -86.80M | $ -102.23M | $ -99.52M | $ -84.83M |
| Net Income | $ -6.88M | $ -88.98M | $ -104.70M | $ -101.07M | $ -85.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 284.67M | $ 216.90M | $ 201.39M | $ 229.59M | $ 219.81M |
| Total Assets | $ 418.43M | $ 271.56M | $ 228.34M | $ 256.07M | $ 238.87M |
| Total Debt | $ 3.01M | $ 4.77M | $ 2.06M | $ 2.36M | $ 5.04M |
| Net Debt | $ -81.21M | $ -123.21M | $ -189.38M | $ -111.20M | $ -139.86M |
| Total Liabilities | $ 65.98M | $ 42.53M | $ 68.78M | $ 71.22M | $ 21.09M |
| Stockholders' Equity | $ 352.46M | $ 229.02M | $ 159.56M | $ 184.85M | $ 217.78M |
| Cash Flow | |||||
| Free Cash Flow | $ 44.91M | $ -87.05M | $ -82.68M | $ -35.83M | $ -68.11M |
| Operating Cash Flow | $ 45.59M | $ -86.85M | $ -81.07M | $ -31.87M | $ -66.91M |
| Investing Cash Flow | $ -186.81M | $ -107.47M | $ 105.95M | $ -45.88M | $ -76.43M |
| Financing Cash Flow | $ 97.39M | $ 131.09M | $ 53.01M | $ 46.41M | $ 1.28M |
Currency in USD
